CCL7 and ovarian cancer: The upregulation of CCL7 in macrophages stimulated with the CM of ovarian cancer cells (both A2780-CM and OVCAR3-CM) was significantly negated by the p38 inhibitor, SB203580, and the JNK inhibitor, SP600125 (Figure 4A).